nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—CHRM1—GPCR ligand binding—HCRTR1—narcolepsy	0.00304	0.00304	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—HCRTR2—narcolepsy	0.00303	0.00303	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—HCRTR1—narcolepsy	0.00303	0.00303	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—HCRTR2—narcolepsy	0.00301	0.00301	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—HCRTR1—narcolepsy	0.00301	0.00301	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—P2RY11—narcolepsy	0.00294	0.00294	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—P2RY11—narcolepsy	0.00293	0.00293	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00293	0.00293	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00292	0.00292	CbGpPWpGaD
Scopolamine—CHRM3—GPCRs, Other—HTR2A—narcolepsy	0.00291	0.00291	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—P2RY11—narcolepsy	0.0029	0.0029	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00289	0.00289	CbGpPWpGaD
Scopolamine—CHRM2—GPCRs, Other—HTR2A—narcolepsy	0.00288	0.00288	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—TRH—narcolepsy	0.00281	0.00281	CbGpPWpGaD
Scopolamine—CHRM1—G alpha (q) signalling events—TAC1—narcolepsy	0.00273	0.00273	CbGpPWpGaD
Scopolamine—CHRM1—G alpha (q) signalling events—NPS—narcolepsy	0.00273	0.00273	CbGpPWpGaD
Scopolamine—CHRM3—G alpha (q) signalling events—TAC1—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Scopolamine—CHRM3—G alpha (q) signalling events—NPS—narcolepsy	0.00272	0.00272	CbGpPWpGaD
Scopolamine—CHRM2—G alpha (i) signalling events—HRH3—narcolepsy	0.00271	0.00271	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—TRH—narcolepsy	0.00269	0.00269	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00268	0.00268	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00268	0.00268	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—HLA-DQA1—narcolepsy	0.00265	0.00265	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—NPS—narcolepsy	0.00258	0.00258	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00257	0.00257	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—HCRTR1—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—HCRTR2—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Scopolamine—CHRM1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00255	0.00255	CbGpPWpGaD
Scopolamine—CHRM3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00254	0.00254	CbGpPWpGaD
Scopolamine—CHRM2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00251	0.00251	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—HCRT—narcolepsy	0.0025	0.0025	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—HCRT—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00249	0.00249	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—HLA-DQB1—narcolepsy	0.00248	0.00248	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—HCRT—narcolepsy	0.00247	0.00247	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—P2RY11—narcolepsy	0.00246	0.00246	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—HRH3—narcolepsy	0.00246	0.00246	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00246	0.00246	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—HCRTR1—narcolepsy	0.00244	0.00244	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—HCRTR2—narcolepsy	0.00244	0.00244	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00244	0.00244	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00244	0.00244	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00243	0.00243	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00243	0.00243	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—P2RY11—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—HRH3—narcolepsy	0.00236	0.00236	CbGpPWpGaD
Scopolamine—CHRM5—G alpha (q) signalling events—HTR2A—narcolepsy	0.00233	0.00233	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HCRTR1—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HCRTR2—narcolepsy	0.00232	0.00232	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—P2RY11—narcolepsy	0.00224	0.00224	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—PENK—narcolepsy	0.00223	0.00223	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—PENK—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HCRTR2—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HCRTR1—narcolepsy	0.00222	0.00222	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—PENK—narcolepsy	0.0022	0.0022	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00218	0.00218	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00217	0.00217	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00215	0.00215	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—P2RY11—narcolepsy	0.00214	0.00214	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—HCRT—narcolepsy	0.0021	0.0021	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00209	0.00209	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—TAC1—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—NPS—narcolepsy	0.00204	0.00204	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—HCRT—narcolepsy	0.00201	0.00201	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—NPS—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—TAC1—narcolepsy	0.00196	0.00196	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HCRT—narcolepsy	0.0019	0.0019	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—TRH—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—TRH—narcolepsy	0.00189	0.00189	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—HLA-DRB1—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Scopolamine—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00188	0.00188	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00187	0.00187	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—TRH—narcolepsy	0.00187	0.00187	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—PENK—narcolepsy	0.00187	0.00187	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HCRT—narcolepsy	0.00182	0.00182	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00181	0.00181	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00181	0.00181	CbGpPWpGaD
Scopolamine—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.0018	0.0018	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.0018	0.0018	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.0018	0.0018	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—PENK—narcolepsy	0.00179	0.00179	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00178	0.00178	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—HCRTR2—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—HCRTR1—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—HCRTR2—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—HCRTR1—narcolepsy	0.00172	0.00172	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—HCRTR1—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—HCRTR2—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PENK—narcolepsy	0.0017	0.0017	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—P2RY11—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—HRH3—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—P2RY11—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—HRH3—narcolepsy	0.00166	0.00166	CbGpPWpGaD
Scopolamine—CHRM1—G alpha (q) signalling events—HTR2A—narcolepsy	0.00164	0.00164	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—P2RY11—narcolepsy	0.00164	0.00164	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—HRH3—narcolepsy	0.00164	0.00164	CbGpPWpGaD
Scopolamine—CHRM3—G alpha (q) signalling events—HTR2A—narcolepsy	0.00164	0.00164	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PENK—narcolepsy	0.00162	0.00162	CbGpPWpGaD
Scopolamine—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00161	0.00161	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—TRH—narcolepsy	0.00159	0.00159	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HCRTR2—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HCRTR1—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HCRTR1—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HCRTR2—narcolepsy	0.00156	0.00156	CbGpPWpGaD
Scopolamine—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HCRTR1—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HCRTR2—narcolepsy	0.00154	0.00154	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—TRH—narcolepsy	0.00152	0.00152	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—P2RY11—narcolepsy	0.00151	0.00151	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—P2RY11—narcolepsy	0.0015	0.0015	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—P2RY11—narcolepsy	0.00149	0.00149	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00147	0.00147	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.00146	0.00146	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—TRH—narcolepsy	0.00144	0.00144	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—HCRT—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—HCRT—narcolepsy	0.00141	0.00141	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—HCRT—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—HRH3—narcolepsy	0.00139	0.00139	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—TRH—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—NPS—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—TAC1—narcolepsy	0.00138	0.00138	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—TAC1—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—NPS—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HCRTR2—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HCRTR1—narcolepsy	0.00137	0.00137	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—TAC1—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—NPS—narcolepsy	0.00136	0.00136	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—HRH3—narcolepsy	0.00133	0.00133	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—P2RY11—narcolepsy	0.00132	0.00132	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HCRTR2—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HCRTR1—narcolepsy	0.00131	0.00131	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HCRT—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HCRT—narcolepsy	0.00128	0.00128	CbGpPWpGaD
Scopolamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HCRT—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—P2RY11—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Scopolamine—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00127	0.00127	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HRH3—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—PENK—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—PENK—narcolepsy	0.00126	0.00126	CbGpPWpGaD
Scopolamine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00125	0.00125	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CHKB—narcolepsy	0.00125	0.00125	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—PENK—narcolepsy	0.00124	0.00124	CbGpPWpGaD
Scopolamine—CHRM4—GPCR ligand binding—HTR2A—narcolepsy	0.00123	0.00123	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HRH3—narcolepsy	0.00121	0.00121	CbGpPWpGaD
Scopolamine—CHRM5—GPCR ligand binding—HTR2A—narcolepsy	0.00118	0.00118	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—TAC1—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—NPS—narcolepsy	0.00115	0.00115	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PENK—narcolepsy	0.00114	0.00114	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PENK—narcolepsy	0.00114	0.00114	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PENK—narcolepsy	0.00113	0.00113	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HCRT—narcolepsy	0.00112	0.00112	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—NPS—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—TAC1—narcolepsy	0.0011	0.0011	CbGpPWpGaD
Scopolamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00109	0.00109	CbGpPWpGaD
Scopolamine—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HCRT—narcolepsy	0.00108	0.00108	CbGpPWpGaD
Scopolamine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—TRH—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—TRH—narcolepsy	0.00107	0.00107	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—TRH—narcolepsy	0.00106	0.00106	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—NPS—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—TAC1—narcolepsy	0.00105	0.00105	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—NPS—narcolepsy	0.001	0.001	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—TAC1—narcolepsy	0.001	0.001	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PENK—narcolepsy	0.001	0.001	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—TRH—narcolepsy	0.000972	0.000972	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—TRH—narcolepsy	0.000969	0.000969	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—TRH—narcolepsy	0.00096	0.00096	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PENK—narcolepsy	0.000959	0.000959	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—HRH3—narcolepsy	0.000939	0.000939	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—HRH3—narcolepsy	0.000936	0.000936	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—HRH3—narcolepsy	0.000927	0.000927	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HCRTR1—narcolepsy	0.000923	0.000923	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HCRTR2—narcolepsy	0.000923	0.000923	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HCRTR1—narcolepsy	0.00092	0.00092	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HCRTR2—narcolepsy	0.00092	0.00092	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HCRTR1—narcolepsy	0.000911	0.000911	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HCRTR2—narcolepsy	0.000911	0.000911	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—P2RY11—narcolepsy	0.000891	0.000891	CbGpPWpGaD
Scopolamine—ABCB1—Allograft Rejection—TNF—narcolepsy	0.00089	0.00089	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—P2RY11—narcolepsy	0.000889	0.000889	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—P2RY11—narcolepsy	0.00088	0.00088	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HRH3—narcolepsy	0.000853	0.000853	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TRH—narcolepsy	0.000852	0.000852	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HRH3—narcolepsy	0.00085	0.00085	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CPT1B—narcolepsy	0.00085	0.00085	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HRH3—narcolepsy	0.000842	0.000842	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—HTR2A—narcolepsy	0.000828	0.000828	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—HTR2A—narcolepsy	0.000826	0.000826	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—HTR2A—narcolepsy	0.000818	0.000818	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TRH—narcolepsy	0.000816	0.000816	CbGpPWpGaD
Scopolamine—CHRM2—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000806	0.000806	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CHKB—narcolepsy	0.000793	0.000793	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—TAC1—narcolepsy	0.000778	0.000778	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—NPS—narcolepsy	0.000778	0.000778	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—NPS—narcolepsy	0.000776	0.000776	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—TAC1—narcolepsy	0.000776	0.000776	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—NPS—narcolepsy	0.000768	0.000768	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—TAC1—narcolepsy	0.000768	0.000768	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HCRT—narcolepsy	0.000758	0.000758	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HCRT—narcolepsy	0.000756	0.000756	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HCRT—narcolepsy	0.000748	0.000748	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HRH3—narcolepsy	0.000747	0.000747	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HRH3—narcolepsy	0.000715	0.000715	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—TAC1—narcolepsy	0.000706	0.000706	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—NPS—narcolepsy	0.000706	0.000706	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—TAC1—narcolepsy	0.000704	0.000704	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—NPS—narcolepsy	0.000704	0.000704	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—TAC1—narcolepsy	0.000697	0.000697	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—NPS—narcolepsy	0.000697	0.000697	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—HTR2A—narcolepsy	0.000694	0.000694	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PENK—narcolepsy	0.000676	0.000676	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PENK—narcolepsy	0.000673	0.000673	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PENK—narcolepsy	0.000667	0.000667	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—HTR2A—narcolepsy	0.000665	0.000665	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HTR2A—narcolepsy	0.00063	0.00063	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TAC1—narcolepsy	0.000619	0.000619	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NPS—narcolepsy	0.000619	0.000619	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HTR2A—narcolepsy	0.000604	0.000604	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TAC1—narcolepsy	0.000593	0.000593	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NPS—narcolepsy	0.000593	0.000593	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TRH—narcolepsy	0.000574	0.000574	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TRH—narcolepsy	0.000573	0.000573	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TRH—narcolepsy	0.000567	0.000567	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CPT1B—narcolepsy	0.000539	0.000539	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HRH3—narcolepsy	0.000504	0.000504	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HRH3—narcolepsy	0.000502	0.000502	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HRH3—narcolepsy	0.000497	0.000497	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—HTR2A—narcolepsy	0.000468	0.000468	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—HTR2A—narcolepsy	0.000467	0.000467	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—HTR2A—narcolepsy	0.000462	0.000462	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—narcolepsy	0.000439	0.000439	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HTR2A—narcolepsy	0.000425	0.000425	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HTR2A—narcolepsy	0.000424	0.000424	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HTR2A—narcolepsy	0.00042	0.00042	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NPS—narcolepsy	0.000417	0.000417	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TAC1—narcolepsy	0.000417	0.000417	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NPS—narcolepsy	0.000416	0.000416	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TAC1—narcolepsy	0.000416	0.000416	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TAC1—narcolepsy	0.000412	0.000412	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NPS—narcolepsy	0.000412	0.000412	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HTR2A—narcolepsy	0.000372	0.000372	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HTR2A—narcolepsy	0.000357	0.000357	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HTR2A—narcolepsy	0.000251	0.000251	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HTR2A—narcolepsy	0.00025	0.00025	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HTR2A—narcolepsy	0.000248	0.000248	CbGpPWpGaD
